Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 Models

被引:128
作者
Dulla, Kalyan [1 ]
Aguila, Monica [2 ]
Lane, Amelia [2 ]
Jovanovic, Katarina [2 ]
Parfitt, David A. [2 ]
Schulkens, Iris [1 ]
Chan, Hee Lam [1 ]
Schmidt, Iris [1 ]
Beumer, Wouter [1 ]
Vorthoren, Lars [1 ]
Collin, Rob W. J. [3 ]
Garanto, Alejandro [3 ]
Duijkers, Lonneke [3 ]
Brugulat-Panes, Anna [2 ]
Semo, Ma'ayan [2 ]
Vugler, Anthony A. [2 ]
Biasutto, Patricia [1 ]
Adamson, Peter [1 ,2 ]
Cheetham, Michael E. [2 ]
机构
[1] ProQR Therapeut, Zernikedreef 9, NL-2333 CK Leiden, Netherlands
[2] UCL Inst Ophthalmol, 11-43 Bath St, London EC1V 9EL, England
[3] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, Nijmegen, Netherlands
基金
英国惠康基金;
关键词
LEBER CONGENITAL AMAUROSIS; ANTISENSE OLIGONUCLEOTIDES; RETINAL DEGENERATION; DISEASE MECHANISMS; PRIMARY CILIA; GENE-THERAPY; OPTIC CUPS; IN-VITRO; MUTATION; CELLS;
D O I
10.1016/j.omtn.2018.07.010
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Leber congenital amaurosis type 10 (LCA10) is a severe inherited retinal dystrophy associated with mutations in CEP290. The deep intronic c.2991 + 1655A>G mutation in CEP290 is the most common mutation in LCA10 individuals and represents an ideal target for oligonucleotide therapeutics. Here, a panel of antisense oligonucleotides was designed to correct the splicing defect associated with the mutation and screened for efficacy and safety. This identified QR-110 as the best-performing molecule. QR-110 restored wild-type CEP290 mRNA and protein expression levels in CEP290 c.2991 + 1655A>G homozygous and compound heterozygous LCA10 primary fibroblasts. Furthermore, in homozygous three-dimensional iPSC-derived retinal organoids, QR-110 showed a dose-dependent restoration of mRNA and protein function, as measured by percentage and length of photoreceptor cilia, without off-target effects. Localization studies in wild-type mice and rabbits showed that QR-110 readily reached all retinal layers, with an estimated half-life of 58 days. It was well tolerated following intravitreal injection in monkeys. In conclusion, the pharmacodynamic, pharmacokinetic, and safety properties make QR-110 a promising candidate for treating LCA10, and clinical development is currently ongoing.
引用
收藏
页码:730 / 740
页数:11
相关论文
共 50 条
[1]   Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial [J].
Bennett, Jean ;
Wellman, Jennifer ;
Marshall, Kathleen A. ;
McCague, Sarah ;
Ashtari, Manzar ;
DiStefano-Pappas, Julie ;
Elci, Okan U. ;
Chung, Daniel C. ;
Sun, Junwei ;
Wright, J. Fraser ;
Cross, Dominique R. ;
Aravand, Puya ;
Cyckowski, Laura L. ;
Bennicelli, Jeannette L. ;
Mingozzi, Federico ;
Auricchio, Alberto ;
Pierce, Eric A. ;
Ruggiero, Jason ;
Leroy, Bart P. ;
Simonelli, Francesca ;
High, Katherine A. ;
Maguire, Albert M. .
LANCET, 2016, 388 (10045) :661-672
[2]   CEP290 gene transfer rescues Leber congenital amaurosis cellular phenotype [J].
Burnight, E. R. ;
Wiley, L. A. ;
Drack, A. V. ;
Braun, T. A. ;
Anfinson, K. R. ;
Kaalberg, E. E. ;
Haider, J. A. ;
Affatigato, L. M. ;
Mullins, R. F. ;
Stone, E. M. ;
Tucker, B. A. .
GENE THERAPY, 2014, 21 (07) :662-672
[3]   Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal Degeneration [J].
Burnight, Erin R. ;
Gupta, Manav ;
Wiley, Luke A. ;
Anfinson, Kristin R. ;
Tran, Audrey ;
Triboulet, Robinson ;
Hoffmann, Jeremy M. ;
Klaahsen, Darcey L. ;
Andorf, Jeaneen L. ;
Jiao, Chunhua ;
Sohn, Elliott H. ;
Adur, Malavika K. ;
Ross, Jason W. ;
Mullins, Robert F. ;
Daley, George Q. ;
Schlaeger, Thorsten M. ;
Stone, Edwin M. ;
Tucker, Budd A. .
MOLECULAR THERAPY, 2017, 25 (09) :1999-2013
[4]   In-frame deletion in a novel centrosomal/ciliary protein CEP290/NPHP6 perturbs its interaction with RPGR and results in early-onset retinal degeneration in the rd16 mouse [J].
Chang, Bo ;
Khanna, Hemant ;
Hawes, Norman ;
Jimeno, David ;
He, Shirley ;
Lillo, Concepcion ;
Parapuram, Sunil K. ;
Cheng, Hong ;
Scott, Alison ;
Hurd, Ron E. ;
Sayer, John A. ;
Otto, Edgar A. ;
Attanasio, Massimo ;
O'Toole, John F. ;
Jin, Genglin ;
Shou, Chengchao ;
Hildebrandt, Friedhelm ;
Williams, David S. ;
Heckenlively, John R. ;
Swaroop, Anand .
HUMAN MOLECULAR GENETICS, 2006, 15 (11) :1847-1857
[5]   Antisense Oligonucleotide (AON)-based Therapy for Leber Congenital Amaurosis Caused by a Frequent Mutation in CEP290 [J].
Collin, Rob W. J. ;
den Hollander, Anneke I. ;
van der Velde-Visser, Saskia D. ;
Bennicelli, Jeannette ;
Bennett, Jean ;
Cremers, Frans P. M. .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2012, 1 :e14
[6]   CEP290, a Gene with Many Faces: Mutation Overview and Presentation of CEP290base [J].
Coppieters, Frauke ;
Lefever, Steve ;
Leroy, Bart P. ;
De Baere, Elfride .
HUMAN MUTATION, 2010, 31 (10) :1097-1108
[7]   Fomivirsen - a phosphorothioate oligonucleotide for the treatment of CMV retinitis [J].
de Smet, MD ;
Meenken, C ;
van den Horn, GJ .
OCULAR IMMUNOLOGY AND INFLAMMATION, 1999, 7 (3-4) :189-198
[8]   Inflammation and immunogenicity limit the utility of the rabbit as a nonclinical species for ocular biologic therapeutics [J].
de Zafra, Christina L. Zuch ;
Sasseville, Vito G. ;
Matsumoto, Steven ;
Freichel, Christian ;
Milton, Mark ;
MacLachlan, Timothy K. ;
Farman, Cindy ;
Raymond, Iona ;
Gupta, Swati ;
Newton, Ronald ;
Atzpodien, Elke-Astrid ;
Thackaberry, Evan A. .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2017, 86 :221-230
[9]   Leber congenital amaurosis: Genes, proteins and disease mechanisms [J].
den Hollander, Anneke I. ;
Roepman, Ronald ;
Koenekoop, Robert K. ;
Cremers, Frans P. M. .
PROGRESS IN RETINAL AND EYE RESEARCH, 2008, 27 (04) :391-419
[10]   Mutations in the CEP290 (NPHP6) gene are a frequent cause of leber congenital amaurosis [J].
den Hollander, Anneke I. ;
Koenekoop, Robert K. ;
Yzer, Suzanne ;
Lopez, Irma ;
Arends, Maarten L. ;
Voesenek, Krysta E. J. ;
Zonneveld, Marijke N. ;
Strom, Tim M. ;
Meitinger, Thomas ;
Brunner, Han G. ;
Hoyng, Carel B. ;
van den Born, L. Ingeborgh ;
Rohrschneider, Klaus ;
Cremers, Frans P. M. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2006, 79 (03) :556-561